• Medical Devices
  • News

Medical Devices and EU 2017/745, exclusive interview

The legislation governing medical devices (MDs) having largely demonstrated its ineffectiveness during the PIP implant scandal, the new 2017/745 regulation reinforces patient safety by introducing clinical evaluation of the MD, post-market surveillance and a unique identification system for better traceability is more transparency. Stéphane ANCEL, Commercial Director at Ackomas, presents Ackomas' approach and its innovative…

ackomas

For ackomas, the 17 Jan 2024

Reading time: 1 min.

  • News

Ackomas and Nexialist co-present a webinar focusing on Eudamed

Nexialist organized a webinar dedicated to Eudamed, the European medical device database. The implementation of European regulations EU2017/745 MDR and EU2017/746 IVDR continues to raise questions for medical device manufacturers. For this reason, Nexialist, the consulting firm specializing in regulatory intelligence and compliance for healthcare products, recently organized a webinar on the subject and invited…

ackomas

For ackomas, the 15 Nov 2023

Reading time: 1 min.

  • Medical Devices
  • News

Published in DeviceMed France

Published at the beginning of September, DeviceMed France's latest issue looks at Eudamed compliance, the means to achieve it and the urgent need to implement suitable tools, featuring KOA software, a SaaS solution developed by Ackomas. Happy reading! Download the article

ackomas

For ackomas, the 12 Sep 2023

Reading time: 1 min.

  • Medical Devices
  • News

Webinar – Practical questions about Eudamed compliance

The timetable for the implementation of regulations EU 2017/745 and EU 2017/746 continues to unfold, with an important next step: the operational qualification of the EUDAMED database. This step, which makes mandatory the publication of data on Medical Devices and In Vitro Diagnostics, still raises many questions among industry professionals. Ackomas is organizing a webinar…

ackomas

For ackomas, the 06 Jul 2023

Reading time: 2 min.

  • News

Ackomas participates at Medi’nov Connection

On May 1st and June 1st, Ackomas will exhibit at the Medi'nov Connection 2023 which will take place at the Lyon Convention Center. Medi'nov Connection is one of the world's leading events in medical innovation and has become a must-attend event for all actors in the field of health technologies. On this occasion, Stéphane Ancel,…

ackomas

For ackomas, the 23 May 2023

Reading time: 1 min.

  • News

Ackomas will meet you at Techinnov

For the past 17 years, innovation has been the main focus of Techinnov convention. This major event, organized by the Chambers of Commerce and Industry of Paris Ile de France and Essonne, gathers every year more than 600 start-ups, companies and research structures that present their innovative solutions to visitors. Techinnov also includes a rich…

ackomas

For ackomas, the 24 Jan 2023

Reading time: 1 min.

  • News

Happy Season Holiday

As the year 2022 will soon come to an end, the entire Ackomas team would like to thank you for your trust and for this year rich in new collaborations. We wish you a wonderful holiday season and for the year ahead, many successes, creativity, dynamism, without forgetting joy and prosperity. We wish you all…

ackomas

For ackomas, the 24 Dec 2022

Reading time: 1 min.

  • News

Meet Ackomas at Euro-Pharmat

Come meet Ackomas and @GP аt Euro Pharmat [1] – the 32nd National Medical Device Training Days will be held at Espace Encan in La Rochelle, from 4-6 October 2022. Ackomas will be able to answer аll of your questions about traceability, unit identification, Eudamed registration, as well as the current regulation and how we…

ackomas

For ackomas, the 05 Oct 2022

Reading time: 1 min.

The authors

ackomas

ackomas

Learn more

Was this content helpful?

Thank you

Thank you for taking the time to let us know that this content was useful to you. Your encouragement is important to us, and your feedback helps us improve.

Thank you

Thank you for taking the time to let us know that this content was not useful to you. We apologize for the inconvenience.

Suggestion d'amélioration de contenu
Fields marked with * are mandatory